## Clarithromycin-Midazolam-DDI
Modeling of published clinical Clarithromycin-Midazolam-DDI studies for model evaluation 

![gim](https://github.com/Open-Systems-Pharmacology/Clarithromycin-Midazolam-DDI/blob/master/Clarithromycin-Midazolam-DDI.png)

### Repository files
Within this repository, we distribute a PK-Sim project file containing simulations of all published clinical studies used to evaluate the predictive performance of our models regarding the Clarithromycin-Midazolam-DDI, including the respective observed data digitized from literature reports. For further details and documentation please refer to [[1](#reference)]. 

### License
The model is distributed under the [GPLv2 License](https://github.com/Open-Systems-Pharmacology/Suite/blob/develop/LICENSE). 

### Reference
[1] [Hanke N, Frechen S, Moj D, Britz H, Eissing T, Wendl T, Lehr T. PBPK models for CYP3A4 and P-gp DDI prediction: a modeling network of rifampicin, itraconazole, clarithromycin, midazolam, alfentanil and digoxin. CPT: Pharmacometrics & Systems Pharmacology (2018), https://doi.org/10.1002/psp4.12343.](https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/psp4.12343) 
